Case Study: a global pharmaceutical company improves COPD product targeting with Optimal Strategix Group (OSG)

Optimization Regarding Client Enquiry of COPD Treatment

Optimal Strategix Group (OSG) was engaged by a global pharmaceutical company that sought to understand the market dynamics for Chronic Obstructive Pulmonary Disease (COPD) treatment. The client needed to assess the receptivity to its developmental compounds and identify how to best position its future products to meet unmet needs and maximize profitability.

OSG implemented a two-phase qualitative study, utilizing its o360™ consumer targeting technology, which involved in-depth interviews with physicians across the United States. The solution mapped the COPD buying process, evaluated specific product profiles, and identified target patient types. As a result, OSG provided the client with a clear marketing strategy, measuring the volume for each Target Product Profile (TPP), pinpointing ideal positioning against competitors, and revealing opportunities to increase product appeal to the largest group of consumers.